Health Legislation

The law defines the legal framework for the prevention and comprehensive care of the human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS). The law includes the rights and obligations of people living with HIV as well as the prevention and prohibition of discriminatory practices. The law includes as well the treatments in the health system in Cabo Verde among other issues.

The Regulation sets up rules in the registration of drugs and related products manufactured, imported, exported, advertised, sold, distributed or used in Nigeria.  

Specifications for essential medicines supplies.

These Regulations provide rules on the registration and access to the market to medicine; licensing requirements for pharmaceutical operations, manufacturers, wholesalers and dispensaries; as well as on record-keeping, import of medicines, and clinical trials, etc.

This Act makes provision for the prevention and management of HIV and AIDS; provides for the rights and obligations of persons living with HIV or affected by HIV and AIDS; provides for the establishment of the National AIDS Commission; and provides for matters incidental thereto or connected therewith.

This document provides norms and guidelines for HIV prevention for some specific groups.

This Order establishes the National Program for the Fight against STIs/HIV/AIDS (PNLS) created within the Directorate for the Fight against Diseases at the Ministry of Health.

This Law establishes the rules for the efficient and safe production, distribution, use and availability, as well as quality assurance of medicines, vaccines, biological and health products for citizens.

The Ghana AIDS Commission Act, 2016 is to establish the Ghana AIDS commission and the National HIV and AIDS Fund, to provide for the management of the Fund, to prevent and control the HIV and AIDS epidemic, to promote and protect the rights of persons living with HIV or AIDS and to provide for related purposes.

These are the guidelines for the registration, renewal, change in characteristics and extension in range of both imported and locally manufactured registered pharmaceutical products.

This law provides for the Labour Code, establishing the rules governing the relations between employers and (salaried) employees in the country.

This document provides guidelines on the supply of essential medicines in the Democratic Republic of Congo.

This Ministerial decree regulates the trade of pharmaceutical products in the Democratic Republic of the Congo.

The purpose of the law is to determine the fundamental principles of the control of HIV and AIDS in Niger.

This regulation is issued to implement the Food Medicine and Health Care Administration and Control Proclamation No 661/2009. and covers among other aspects of food safety and quality which includes manufacturing, storage and transportation among other aspects; sale of alcohol; medicine administration and control which includes manufacturing, registration, storage, transportation, importation ad clinical trials among others; traditional and complementary medicine administration and control; post-marketing surveillance; control of tobacco products and places prohibited for smoking among other aspects.  

The Act regulates the quality and safety of medicines and related products and connected matters.

These Regulations govern the issuance of licenses for the importation, exportation, manufacture, distribution, and retail of drugs, etc.

This Act provides for the registration, regulation of the sale, distribution, importation, exportation, manufacture and dispensing of medicines and related substances, and matters incidental thereto.

The Revised Guidelines (4th edition) for Prevention of Mother-to-Child Transmission (PMTCT) of HIV and AIDS provide more detailed and effective interventions to reduce the risk of mother-to-child transmission (MTCT) than previous editions. They emphasize the early initiation of ARV prophylaxis starting at 14 weeks, highlighting the importance of early antenatal care (ANC) attendance for all women.

These guidelines outline standardized protocols for the initiation and management of HIV treatment, emphasizing early treatment initiation and adherence to improve health outcomes. They incorporate recommendations for monitoring treatment efficacy, managing side effects, and addressing co-infections, ensuring a patient-centered approach in diverse healthcare settings.